MedPath

SPECIALISED THERAPEUTICS ALIM PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

TGA:5

Drug Approvals

MINJUVI tafasitamab 200 mg powder for solution for infusion 1 vial per carton (387298)

Product Name
MINJUVI tafasitamab 200 mg powder for solution for infusion 1 vial per carton
Approval Date
Jun 20, 2023
TGA

PEMAZYRE pemigatinib 9 mg tablet blister pack (373031)

Product Name
PEMAZYRE pemigatinib 9 mg tablet blister pack
Approval Date
Sep 14, 2022
TGA

PEMAZYRE pemigatinib 4.5 mg tablet blister pack (375309)

Product Name
PEMAZYRE pemigatinib 4.5 mg tablet blister pack
Approval Date
Sep 14, 2022
TGA

PEMAZYRE pemigatinib 13.5 mg tablet blister pack (375314)

Product Name
PEMAZYRE pemigatinib 13.5 mg tablet blister pack
Approval Date
Sep 14, 2022
TGA

ILUVIEN fluocinolone acetonide 190 mcg intravitreal implant in applicator (306543)

Product Name
ILUVIEN fluocinolone acetonide 190 mcg intravitreal implant in applicator
Approval Date
Aug 6, 2019
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.